Evidence map›Paper›PMID 31260168›Full record

ReviewWiley interdisciplinary reviews. Systems biology and medicine2019

Agent-based models of inflammation in translational systems biology: A decade later.

Yoram Vodovotz, Gary An

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Systems biology and medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yoram VodovotzDepartment of Surgery, Immunology, Computational & Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-4389-8768
Gary AnDepartment of Surgery, University of Vermont, Burlington, Vermont.ORCID 0000-0003-4549-9004

Funding

Agent-based Models to address the Crisis of Reproducibility and Precision MedicineU01EB025825 · NIBIB · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI AN, GARY, FAISSOL, DANIEL M · 2018 to 2021
$2.3M
Adaptive Simulation to Enable Anatomic-scale Agent-basedR01GM115839 · NIGMS · UNIVERSITY OF CHICAGO · PI AN, GARY, MACAL, CHARLES MARTIN · 2015 to 2017
$1.2M
A Biohybrid Device for Regulating Inflammation in SepsisR01GM107231 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GERLACH, JOERG C., VODOVOTZ, YORAM · 2015 to 2017
$1.0M
NIBIB NIH HHS U01 EB025825NIBIB NIH HHS U01-EB025825NIGMS NIH HHS R01 GM107231NIGMS NIH HHS R01 GM115839NIGMS NIH HHS R01-GM115839NIGMS NIH HHS RO1-GM107231
6 · The paper itself

Abstract

Agent-based modeling is a rule-based, discrete-event, and spatially explicit computational modeling method that employs computational objects that instantiate the rules and interactions among the individual components ("agents") of system. Agent-based modeling is well suited to translating into a computational model the knowledge generated from basic science research, particularly with respect to translating across scales the mechanisms of cellular behavior into aggregated cell population dynamics manifesting at the tissue and organ level. This capacity has made agent-based modeling an integral method in translational systems biology (TSB), an approach that uses multiscale dynamic computational modeling to explicitly represent disease processes in a clinically relevant fashion. The initial work in the early 2000s using agent-based models (ABMs) in TSB focused on examining acute inflammation and its intersection with wound healing; the decade since has seen vast growth in both the application of agent-based modeling to a wide array of disease processes as well as methodological advancements in the use and analysis of ABM. This report presents an update on an earlier review of ABMs in TSB and presents examples of exciting progress in the modeling of various organs and diseases that involve inflammation. This review also describes developments that integrate the use of ABMs with cutting-edge technologies such as high-performance computing, machine learning, and artificial intelligence, with a view toward the future integration of these methodologies. This article is categorized under: Translational, Genomic, and Systems Medicine > Translational Medicine Models of Systems Properties and Processes > Mechanistic Models Models of Systems Properties and Processes > Organ, Tissue, and Physiological Models Models of Systems Properties and Processes > Organismal Models.

Indexed as

Deep LearningGastrointestinal DiseasesHumansInflammationLiver DiseasesLung DiseasesSepsisSystems Biologyagent-based modelinflammationmathematical modeltranslational systems biology

Identifiers

PMID31260168
PMCPMC8140858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.